AI
TMO icon

Axiom Investors’s Thermo Fisher Scientific TMO Stock Holding History

Axiom Investors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-92,763
Closed -$27.2M – 125
2019
Q2 		$27.2M Buy
92,763
+115
+0.1% +$31.7K 0.75% 37
2019
Q1 		$25.4M Sell
92,648
-55
-0.1% -$13.7K 0.78% 35
2018
Q4 		$20.7M Buy
92,703
+7,690
+9% +$1.8M 0.72% 41
2018
Q3 		$20.8M Sell
85,013
-113
-0.1% -$26K 0.59% 44
2018
Q2 		$17.6M Sell
85,126
-8,479
-9% -$1.8M 0.53% 47
2018
Q1 		$19.3M Buy
+93,605
New +$19.6M 0.47% 53

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Axiom Investors's TMO Position: Q3 2019 in Review

Axiom Investors sold out of Thermo Fisher Scientific (TMO) in Q3 2019, closing a stake of 92,763 shares — an estimated $27.2M sold.

Axiom Investors first reported a position in TMO in Q1 2018 and held it in 6 quarters. The position peaked at $27.2M in Q2 2019. 1,543 funds tracked by Wall St. Rank hold TMO as of Q3 2019.

  • Axiom Investors reported no remaining Thermo Fisher Scientific position as of Q3 2019 after selling out during the quarter.
  • Axiom Investors sold 92,763 Thermo Fisher Scientific shares in Q3 2019, an estimated $27.2M.
  • Axiom Investors first reported a position in Thermo Fisher Scientific in Q1 2018 and held it in 6 quarters.
  • Axiom Investors's Thermo Fisher Scientific position peaked at $27.2M in Q2 2019.
  • 1,543 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2019.

Based on Axiom Investors's 13F filing for Q3 2019, filed 13 Nov 2019.